Oxidative Stress in Brain Ischemia
Tóm tắt
Brain ischemia initiates a complex cascade of metabolic events, several of which involve the generation of nitrogen and oxygen free radicals. These free radicals and related reactive chemical species mediate much of damage that occurs after transient brain ischemia, and in the penumbral region of infarcts caused by permanent ischemia. Nitric oxide, a water‐ and lipid‐soluble free radical, is generated by the action of nitric oxide synthases. Ischemia causes a surge in nitric oxide synthase 1 (NOS 1) activity in neurons and, possibly, glia, increased NOS 3 activity in vascular endothelium, and later an increase in NOS 2 activity in a range of cells including infiltrating neutrophils and macrophages, activated microglia and astrocytes. The effects of ischemia on the activity of NOS 1, a Ca2+‐dependent enzyme, are thought to be secondary to reversal of glutamate reuptake at synapses, activation of NMDA receptors, and resulting elevation of intracellular Ca2+. The up‐regulation of NOS 2 activity is mediated by transcriptional inducers. In the context of brain ischemia, the activity of NOS 1 and NOS 2 is broadly deleterious, and their inhibition or inactivation is neuroprotective. However, the production of nitric oxide in blood vessels by NOS 3, which, like NOS 1, is Ca2+‐dependent, causes vasodilatation and improves blood flow in the penumbral region of brain infarcts. In addition to causing the synthesis of nitric oxide, brain ischemia leads to the generation of superoxide, through the action of nitric oxide synthases, xanthine oxidase, leakage from the mito‐chondrial electron transport chain, and other mechanisms. Nitric oxide and superoxide are themselves highly reactive but can also combine to form a highly toxic an ion, peroxynitrite. The toxicity of the free radicals and peroxynitrite results from their modification of macromolecules, especially DNA, and from the resulting induction of apoptotic and necrotic pathways. The mode of cell death that prevails probably depends on the severity and precise nature of the ischemie injury. Recent studies have emphasized the role of peroxynitrite in causing singlestand breaks in DNA, which activate the DNA repair protein poly(ADP‐ribose) polymerase (PARP). This catalyzes the cleavage and thereby the consumption of NAD+, the source of energy for many vital cellular processes. Over‐activation of PARP, with resulting depletion of NAD+, has been shown to make a major contribution to brain damage after transient focal ischemia in experimental animals. Neuronal accumulation of poly(ADP‐ribose), the end‐product of PARP activity has been demonstrated after brain ischemia in man. Several therapeutic strategies have been used to try to prevent oxidative damage and its consequences after brain ischemia in man. Although some of the drugs used in early studies were ineffective or had unacceptable side effects, other trials with antioxidant drugs have proven highly encouraging. The findings in recent animal studies are likely to lead to a range of further pharmacological strategies to limit brain injury in stroke patients.
Từ khóa
Tài liệu tham khảo
Chopp M, 1996, Apoptosis in focal cerebral ischemia, Ada Neurochir, 66, 21
Dalkara T, 1994, The complex role of nitric oxide in the pathophysiology of focal cerebral ischemia, Brain Pathol, 1994, 49, 10.1111/j.1750-3639.1994.tb00810.x
Endres M, 1997, Ischemie brain injury is mediated by the activation of poly(ADP‐ribose)polymerase, J Cereb Blood Flow Metab, 17, 1143, 10.1097/00004647-199711000-00002
Gale EA, 1996, Molecular mechanisms of β‐cell destruction in IDDM: the role of nicotinamide, Hormone Res, 1, 39
Hibbs JB, 1987, L‐arginine is required for expression of the activated macrophage effector mechanism causing selective inhibition in target cells, J Immunol, 138, 550, 10.4049/jimmunol.138.2.550
Ladecola C, 1997, Delayed reduction of ischemie brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene, J Neurosci, 17, 9157, 10.1523/JNEUROSCI.17-23-09157.1997
Ladecola C, 1995, Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemie damage, Am J Physiol, 268, R286
Lam TT, 1997, The effect of 3‐aminobenzamide, an inhibitor of poly‐ADP‐ribose polymerase, on ischemia/reperfusion damage in rat retina. Res, Comm Molec Pathol Pharmacol, 95, 241
Leist M, 1997, Caspase‐mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide, Molec Wed, 3, 750
Liu PK, 1996, Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia‐reperfusion, J Neurosci, 16, 6795, 10.1523/JNEUROSCI.16-21-06795.1996
Love S, 1998, DNA fragmentation and repair in ischaemic brain injury in man, Neuropathol Appl Neurobiol, 24, 134
LoveS BarberR WilcockGK(1998)Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man.NeuroReportQ:955–959.
LoveS BarberR WilcockGK(In press) Neuronal accumulation of poly(ADP‐ribose) after brain ischaemia.Neuropathol Appl Neurobiol.
Moncada S, 1991, Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacol Rev, 43, 109
Nicotera P, 1997, Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress, Adv Neurol, 72, 95
Obrenovitch TP, 1995, Extracellular neurotransmitter changes in cerebral ischaemia, Cerebrovasc Brain Metab Rev, 7, 1
SpencerJP WongJ JennerA AruomaOI CrossCE HalliwellB(1996)Base modification and strand breakage in isolated calf thymus DNA and in DNA from human skin epidermal keratinocytes exposed to peroxynitrite or 3‐morpholinosydnonimine.Chem Res ToxicolQ:1152–1158.
Szabó C, 1996, DNA strand breakage, activation of poly (ADP‐ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite, Proc Natl Acad Sci USA, 93, 1753, 10.1073/pnas.93.5.1753
Tanaka Y, 1995, Inhibition and down‐regulation of poly(ADP‐ribose) polymerase results in a marked resistance of HL‐60 cells to various apoptosis‐inducers, Cell Molec, 41, 771
WisdenW SeeburgP.(1993).Mammalian ionotropic glutamate receptors.Current Opinion NeurobiolZ:291–298.